DK0889727T3 - Sekventiel estrogen/progesteron-antagonist-kombination til hormonerstatningsterapien - Google Patents

Sekventiel estrogen/progesteron-antagonist-kombination til hormonerstatningsterapien

Info

Publication number
DK0889727T3
DK0889727T3 DK97920535T DK97920535T DK0889727T3 DK 0889727 T3 DK0889727 T3 DK 0889727T3 DK 97920535 T DK97920535 T DK 97920535T DK 97920535 T DK97920535 T DK 97920535T DK 0889727 T3 DK0889727 T3 DK 0889727T3
Authority
DK
Denmark
Prior art keywords
replacement therapy
hormone replacement
progesterone antagonist
antagonist combination
sequential estrogen
Prior art date
Application number
DK97920535T
Other languages
English (en)
Inventor
Kristof Dr Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0889727T3 publication Critical patent/DK0889727T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK97920535T 1996-03-11 1997-03-11 Sekventiel estrogen/progesteron-antagonist-kombination til hormonerstatningsterapien DK0889727T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19610635A DE19610635A1 (de) 1996-03-11 1996-03-11 Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie

Publications (1)

Publication Number Publication Date
DK0889727T3 true DK0889727T3 (da) 2006-07-03

Family

ID=7788657

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97920535T DK0889727T3 (da) 1996-03-11 1997-03-11 Sekventiel estrogen/progesteron-antagonist-kombination til hormonerstatningsterapien

Country Status (16)

Country Link
EP (1) EP0889727B1 (da)
JP (1) JP2000506175A (da)
KR (1) KR19990087672A (da)
AT (1) ATE319454T1 (da)
AU (1) AU2691197A (da)
BR (1) BR9708162A (da)
CA (1) CA2248841C (da)
DE (2) DE19610635A1 (da)
DK (1) DK0889727T3 (da)
ES (1) ES2260792T3 (da)
HU (1) HUP9901474A3 (da)
IL (1) IL126176A (da)
NO (1) NO324613B1 (da)
PL (1) PL328809A1 (da)
PT (1) PT889727E (da)
WO (1) WO1997033589A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834931A1 (de) * 1998-07-28 2000-02-24 Jenapharm Gmbh Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
US7629334B1 (en) 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
HUP0202460A3 (en) * 1999-08-31 2004-04-28 Schering Ag Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist / antagonist to produce a drug for the treatment of vaginitis
EP1210951B1 (en) * 2000-11-30 2005-02-02 Pfizer Products Inc. Composition containing estrogen agonists/antagonists and testosterone for treating a decline in the level of the hormone testosterone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy

Also Published As

Publication number Publication date
AU2691197A (en) 1997-10-01
ES2260792T3 (es) 2006-11-01
DE19610635A1 (de) 1997-09-18
CA2248841C (en) 2008-07-22
KR19990087672A (ko) 1999-12-27
DE59712593D1 (de) 2006-05-04
IL126176A0 (en) 1999-05-09
NO984166D0 (no) 1998-09-10
PL328809A1 (en) 1999-02-15
HUP9901474A3 (en) 2000-02-28
CA2248841A1 (en) 1997-09-18
PT889727E (pt) 2006-07-31
EP0889727B1 (de) 2006-03-08
BR9708162A (pt) 1999-07-27
HUP9901474A2 (hu) 1999-09-28
WO1997033589A1 (de) 1997-09-18
NO324613B1 (no) 2007-11-26
IL126176A (en) 2004-12-15
NO984166L (no) 1998-09-10
JP2000506175A (ja) 2000-05-23
EP0889727A1 (de) 1999-01-13
ATE319454T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
NZ298769A (en) use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception
ATE213947T1 (de) Progestogen-anti-progestogen therapien
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
NL300381I2 (nl) Estradiolvaleraat en dienogest
ATE286725T1 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
ITMI961152A0 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
CO5261567A1 (es) Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
DK0889727T3 (da) Sekventiel estrogen/progesteron-antagonist-kombination til hormonerstatningsterapien
BG101427A (en) Competitive progesterone antagonists for regulating female fertility as required
EP1090639A3 (en) Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator
PL348202A1 (en) Pharmaceutically active composition and dispensing device
ATE212352T1 (de) Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische präparate
HUP0104941A2 (hu) Több gyógyszerformát tartalmazó bliszter
HUP9903097A2 (hu) Progesztogén-antiprogesztogén tartalmú gyógyszerkészítmény
MX9605190A (es) Forma de dosis efectiva para farmacos antiepilepticos.
ECSP003721A (es) Una composicion farmaceutica para ser usada como anticonceptivo
MX9707719A (es) Preparado en combinacion que contiene tramadol y un antagonista del canal de calcio.